In December 1987, Prozac (fluoxetine) was approved by the U.S. Food and Drug Administration (FDA) for the treatment of depression. Within three years a picture of the Prozac capsule appeared on the cover of Newsweek magazine, which hailed it as “a breakthrough drug for depression.” Prozac was the first of a new class of drugs to treat depression called selective serotonin reuptake inhibitors, or SSRIs.
These new antidepressants quickly overtook older antidepressants—such as Pamelor (nortriptyline) and Elavil (amitriptyline), known as tricyclics, and Nardil (phenelzine) and Parnate (tranylcypromine), known as monoamine oxidase inhibitors (MAOIs)—as the most commonly prescribed drugs for depression. Healthcare providers believed the SSRIs were safer and avoided the weight gain common with the tricyclics and the hypertension issues with MAOIs.
Today, SSRI antidepressants remain the most commonly prescribed drugs for depression as well as for certain anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder. Continue reading to learn more about SSRIs including common brand names, uses, safety information, and costs. The table below lists the most common SSRIs currently available.
| Drug name | Learn more | See SingleCare price |
|---|---|---|
| Celexa | celexa details | |
| Citalopram | citalopram-hydrobromide details | |
| Fluvoxamine | fluvoxamine-maleate details | |
| Lexapro | lexapro details | |
| Escitalopram | escitalopram-oxalate details | |
| Paxil | paxil details | |
| Paroxetine | paroxetine-hcl details | |
| Pexeva | pexeva details | |
| Prozac | prozac details | |
| Fluoxetine | fluoxetine-hcl details | |
| Trintellix | trintellix details | |
| Viibryd | viibryd details | |
| Zoloft | zoloft details | |
| Sertraline | sertraline-hcl details |
Symbyax (olanzapine/fluoxetine): a combination antipsychotic drug and SSRI used to treat depressive episodes in bipolar disorder (manic-depressive illness) as well as severe depression that does not respond to other medications.
The development of SSRIs in the 1970s was based on the theory that low serotonin levels played a role in patients who were clinically depressed. Prozac, as well as the other SSRIs that followed, were designed specifically to increase serotonin levels in the brain. This selective activity was a much different mechanism of action from the older antidepressants available at that time.
Serotonin is a neurotransmitter, or chemical messenger, that carries signals between nerve cells, or neurons, in the brain. When the brain sends a message, serotonin is released from one neuron and then picked up and reabsorbed by a receptor on the receiving neuron. SSRIs work by blocking the reabsorption, or reuptake, of serotonin at the receptor of the receiving neuron. This allows for more serotonin, thought to have a positive influence on mood, emotion, and sleep, to be available to improve the transmission of messages between neurons. SSRIs are called selective because their main effect is on serotonin and not on other neurotransmitters.
Premenstrual dysphoric disorder (PMDD)
Antidepressants, including all SSRI medications, have an FDA-mandated “boxed warning,” also called a black box warning, due to increased risk of suicidality in children, adolescents, and young adults (up to 24 years of age). The FDA has approved the following antidepressants for use in children and adolescents for different types of diagnoses:
Prozac for depression and OCD
Zoloft for OCD
Fluvoxamine for OCD
Lexapro for depression
SSRIs are generally considered safe and effective for use in adults unless they have a known hypersensitivity to any of the ingredients.
SSRIs are generally considered safe and effective for use in the elderly unless they have a known hypersensitivity to any of the ingredients. Elderly patients may be at greater risk for hyponatremia, or low sodium levels, when taking SSRIs—this may be addressed by changing to a lower dose or less frequent dosing.
Because they have shown the least potential for drug-drug interactions, the SSRIs considered to have the best safety profile in the elderly are Celexa, Lexapro, and Zoloft.
SSRIs carry a boxed warning regarding a risk of increased suicidal thinking and behavior in some younger patients. Patients of all ages who are started on SSRIs should be monitored for signs of suicidal thoughts and behaviors.
Because SSRIs are thought to work in a similar way they share many of the same warnings:
Serotonin syndrome is a serious and potentially life-threatening condition in which there is too much serotonin in the body. SSRIs work by increasing the levels of serotonin which may lead to excess levels, especially when taken with other drugs that increase serotonin such as triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, dextromethorphan, amphetamines, St. John’s Wort, and monoamine oxidase inhibitors (MAOIs). Symptoms of serotonin syndrome may include high fever, seizures, uneven heartbeat, or passing out. Emergency medical care may be needed if any of these symptoms occur.
When discontinuing an SSRI, withdrawal symptoms, such as agitation, may occur if stopped abruptly. Patients should follow the advice of their healthcare provider on the best way to taper off the drug.
SSRIs may cause a mixed/manic episode in patients with bipolar disorder.
SSRIs should be used cautiously in patients with a history of seizures.
SSRIs may increase the risk of bleeding particularly if used with nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin, ibuprofen, or naproxen, or with anticoagulant drugs such as warfarin.
Angle-closure glaucoma has occurred in patients taking SSRIs with untreated anatomically narrow angles.
Hyponatremia, a condition where the level of sodium in the blood is too low, has been reported with SSRI usage. Symptoms may include nausea, headache, confusion, and fatigue.
Patients on SSRIs may experience significant weight loss, particularly those already underweight.
Some SSRIs may trigger a heart rhythm disturbance and should be used cautiously in patients with risk factors for QT prolongation.
SSRIs have the potential to impair judgment and motor skills and patients should use caution when operating machinery.
SSRIs may increase the chance of causing serious side effects and should be used with caution, or not at all, for those with the following conditions:
During the manic phase of bipolar disorder
Epilepsy (unless the epilepsy is well controlled)
Narrow-angle glaucoma
Serious kidney, liver, or heart problems
When combined with some drugs, SSRIs can interfere with their effectiveness and potentially have dangerous reactions. Individual drug-drug interactions for each specific SSRI may be found in the product details links in the List of SSRIs above. Important interactions common to all SSRIs are the following:
SSRIs should not be taken with MAOIs or within two weeks of taking MAOIs to avoid the risk of serotonin syndrome.
SSRIs should not be taken with other serotonergic, or serotonin increasing, drugs such as serotonin-norepinephrine reuptake inhibitors (SNRIs), triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, or St. John’s Wort.
SSRIs may increase the risk of bleeding when taken with other medications that increase the risk of bleeding, such as NSAIDs (e.g., aspirin or ibuprofen) or blood thinners (e.g., warfarin).
A decision to use SSRIs during pregnancy or while breastfeeding is based on the balance between risk and benefit. The risk of birth defects for babies of mothers who take SSRIs during pregnancy is low, although paroxetine (Paxil, Pexeva) is associated with a small risk of birth defects and its use is discouraged. A woman’s healthcare provider is the best source of information when managing antidepressant treatment when pregnant or breastfeeding.
Although SSRIs are not addictive, missing several doses of any antidepressant in a row or stopping treatment abruptly may cause withdrawal-like symptoms. This is sometimes called discontinuation syndrome and may include the following symptoms:
General feeling of uneasiness
Nausea
Dizziness
Lethargy
Flu-like symptoms
Patients should be monitored for these symptoms when discontinuing treatment with an SSRI. A gradual reduction in the dose rather than abruptly stopping is recommended whenever possible. If intolerable symptoms occur following a decrease in the dose or upon discontinuation of treatment, then resuming the previously prescribed dose may be considered. The healthcare provider may continue decreasing the dose but at a more gradual rate.
No, SSRIs are not controlled substances.
The following are potential common side effects when taking SSRIs. This is not an exhaustive list and you should always consult a healthcare professional before taking SSRIs.
Insomnia
Nausea
Headache
Asthenia (
abnormal weakness or lack of energy)
Diarrhea
Loss of appetite
Drowsiness
Anxiety
Nervousness
Dry mouth
Decreased libido (loss of sex drive)
Yawning
Tremor
Indigestion
Flu syndrome
Dizziness
Excess sweating
Ejaculatory dysfunction
Impotence
Abnormal dreams
Constipation
Rash
Vomiting
Visual disturbance
Weight loss
SSRIs have a wide price range depending on the specific drug, quantity, and dosage. Since several SSRIs are available in generic form, they are much less than the brand name counterpart. For example, generic fluoxetine 20 mg a day costs about $16 a month. The brand name version, Prozac, would cost about $534 a month. Generic citalopram 20 mg a day costs about $14 a month. The brand version, Celexa, would cost about $305 a month. A SingleCare card could reduce certain prescription costs up to 80% at participating pharmacies.
Lexapro vs. Prozac: Differences, similarities, and which is better for you
Zoloft vs. Prozac: Differences, similarities, and which is better for you
Paxil vs. Zoloft: Differences, similarities, and which is better for you
Celexa vs. Prozac: Differences, similarities, and which is better for you
Viibryd vs. Lexapro: Differences, similarities, and which is better for you
Trintellix vs. Viibryd: Differences, similarities, and which is better for you
Sex on antidepressants: Exploring the sexual side effects of SSRIs
Keith Gardner, R.Ph., is a graduate of Southwestern Oklahoma State University School of Pharmacy. He has 10 years of community pharmacy experience followed by a 22-year career with a major pharmaceutical company in which he served as a medical information consultant. In that role, Gardner provided medical information to consumers and healthcare providers in numerous disease states. He currently resides in Monument, Colorado, with his wife and three dogs.
...SingleCare es un servicio de descuentos para medicamentos recetados que ofrece cupones gratuitos para miles de medicamentos. Puedes usarlo aun si tienes seguro, Medicare, Medicaid o no, pero no se puede combinar con el seguro.
SingleCare ofrece transparencia al mostrar los precios de medicamentos para que puedas comparar descuentos en farmacias cerca de ti. Visita singlecare.com para encontrar descuentos en medicamentos, información útil sobre tu receta médica y recursos que te ayudan a tomar decisiones informadas sobre tu salud.
Los ahorros en recetas varían según la receta médica y la farmacia, y pueden alcanzar hasta un 80% de descuento sobre el precio en efectivo. Este es un plan de descuento de recetas médicas. NO es un seguro ni un plan de medicamentos de Medicare. El rango de descuentos para las recetas médicas que se brindan bajo este plan, dependerá de la receta y la farmacia donde se adquiera la receta y puede otorgarse hasta un 80% de descuento sobre el precio en efectivo. Usted es el único responsable de pagar sus recetas en la farmacia autorizada al momento que reciba el servicio, sin embargo, tendrá el derecho a un descuento por parte de la farmacia de acuerdo con el Programa de Tarifas de Descuento que negoció previamente. Towers Administrators LLC (que opera como “SingleCare Administrators”) es la organización autorizada del plan de descuento de recetas médicas ubicada en 4510 Cox Road, Suite 11, Glen Allen, VA 23060. SingleCare Services LLC (“SingleCare”) es la comercializadora del plan de descuento de prescripciones médicas que incluye su sitio web www.singlecare.com. Como información adicional se incluye una lista actualizada de farmacias participantes, así como también asistencia para cualquier problema relacionado con este plan de descuento de prescripciones médicas, comunícate de forma gratuita con el Servicio de Atención al Cliente al 844-234-3057, las 24 horas, los 7 días de la semana (excepto los días festivos). Al utilizar la aplicación o la tarjeta de descuento para recetas médicas de SingleCare acepta todos los Términos y Condiciones, para más información visita: https://www.singlecare.com/es/terminos-y-condiciones. Los nombres, logotipos, marcas y otras marcas comerciales de las farmacias son propiedad exclusiva de sus respectivos dueños.
Los artículos del blog no constituyen asesoramiento médico. Su propósito es brindar información general y no sustituyen el asesoramiento, diagnóstico ni tratamiento médico profesional. Si tiene alguna pregunta sobre una afección médica, consulte siempre a su médico u otro profesional de la salud cualificado. Si cree tener una emergencia médica, llame inmediatamente a su médico o al 911.
© 2025 SingleCare Administrators. Todos los derechos reservados
© 2025 SingleCare Administrators. Todos los derechos reservados